Vaccination News Home Page

http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowAbstract&ProduktNr=224164&Ausgabe=228674&ArtikelNr=65848&ContentOnly=false


Logo Karger

search

Subjectguide
Journals
Books / Serials / Multimedia
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


 
Logo

  Journal Home
  Editorial Board
  Guidelines
  Issues



 


  Advertising
  Subscriptions
  Free ToC Alert
  Online Sample



 
 


Vol. 205, No. 3, 2002 

Free Abstract     Article (Fulltext)     Article (PDF 83 KB)     


Clinical and Laboratory Investigations

Prevention Campaign against Skin Cancer
L.M. Heinzerlinga, R. Dummera, R.G. Panizzonb, P.H. Blochc, R. Barbezatd, G. Burga, and the task force 'Swiss Cancer' of the Swiss Cancer League

aDepartment of Dermatology, University Hospital of Zürich,
bService de dermato-vénéréologie, Département de médecine, Centre hospitalier universitaire vaudois, Lausanne,
cPrivate practice, Solothurn, and
dSwiss Cancer League, Bern, Switzerland
 

Address of Corresponding Author

Dermatology 2002;205:229-233 (DOI: 10.1159/000065848)


 goto top of page Abstract

Background: The melanoma incidence has increased over recent decades. Educational campaigns aim to encourage protection from the sun and early detection of melanoma. Methods: During a campaign in Switzerland, information on risk factors, sun protection and melanoma prevention was distributed. 10,987 people completed a questionnaire regarding risk factors, and 2,746 people were examined by a dermatologist. Results: Men had a higher risk as assessed by skin type, ultraviolet exposure, family history, number of moles and sunburns during childhood. Changes in moles were reported significantly more often by people with: (1) a positive family history (p < 0.0001); (2) multiple moles (p < 0.0001), and (3) sunburns during childhood (p < 0.0001). A precancerous or cancerous condition was suspected in 16% of individuals examined. Conclusion: Early detection of melanoma can be achieved by this type of campaign. Primary prevention is a long-term approach and educational efforts targeting risk groups must be continued.

Copyright © 2002 S. Karger AG, Basel


 goto top of page Author Contacts

Prof. Günter Burg
Dermatologische Klinik, Universitätsspital Zürich
Gloriastrasse 31
CH-8091 Zürich (Switzerland)
Tel. +41 1 255 25 07, Fax +41 1 255 44 18, E-Mail burg@derm.unizh.ch


Free Abstract     Article (Fulltext)     Article (PDF 83 KB)     


 

Logo
  Journal Home
  Editorial Board
  Guidelines
  Issues
 

  Advertising
  Subscriptions
  Free ToC Alert
  Online Sample
 

 


Copyright © 2002 S. Karger AG, Basel

 

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.